Treatment of GLP-1 for Diabetic Bariatric Patients

NCT04624672 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Poor enrollment

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Semaglutide (1 Mg Dose)
DRUG: Placebo

Sponsor

Geisinger Clinic

Collaborators

[object Object]